Brief: Aardvark Therapeutics Announces Establishment Of New U.S. Subsidiary
12/02/2026 14:40
Feb 12 (Reuters) - Aardvark Therapeutics Inc AARD.O: AARDVARK THERAPEUTICS ANNOUNCES ESTABLISHMENT OF NEW U.S. SUBSIDIARY TO SUPPORT DEVELOPMENT OF ITS DERMATOLOGY PIPELINE; BRYAN JONES NAMED CHIEF EXECUTIVE OFFICER Source text: ID:nGNX4C5rg4 Further company coverage: AARD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aardvark Therapeutics
See all newsBrief: Aardvark Therapeutics Appoints Clinical Development Leader David Zhang, Ph.D., Mba, To Its Board Of Directors
Aardvark Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Aardvark Therapeutics Q2 operating expenses fall on paused ARD-101 clinical trials and workforce reduction
Aardvark Therapeutics, Inc. expected to post a loss of 87 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Intel, Nvidia, Aardvark